UBS’s ProShares UltraShort Health Care RXD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$16K Sell
55
-376
-87% -$116K ﹤0.01% 8285
2014
Q2
$141K Buy
431
+383
+798% +$137K ﹤0.01% 5545
2014
Q1
$17K Buy
48
+16
+50% +$6.03K ﹤0.01% 8314
2013
Q4
$13K Sell
32
-34
-52% -$15.4K ﹤0.01% 8708
2013
Q3
$33K Buy
66
+23
+53% +$12K ﹤0.01% 7414
2013
Q2
$25K Buy
+43
New +$25.4K ﹤0.01% 7613

Other funds holding RXD

UBS's RXD Position: Q3 2014 in Review

UBS reduced its ProShares UltraShort Health Care (RXD) stake by 87% in Q3 2014, selling an estimated $116K and leaving 55 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #8285.

UBS first reported a position in RXD in Q2 2013 and has held it in 6 quarters since. The position peaked at $141K in Q2 2014. 4 funds tracked by Wall St. Rank hold RXD as of Q3 2014.

  • UBS held 55 shares of ProShares UltraShort Health Care worth $16K as of Q3 2014.
  • UBS sold 376 ProShares UltraShort Health Care shares in Q3 2014, an estimated $116K.
  • ProShares UltraShort Health Care made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8285 holding.
  • UBS first reported a position in ProShares UltraShort Health Care in Q2 2013 and has held it in 6 quarters since.
  • UBS's ProShares UltraShort Health Care position peaked at $141K in Q2 2014.
  • 4 funds tracked by Wall St. Rank held ProShares UltraShort Health Care as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.